Trust Company
PCVX icon

Trust Company’s Vaxcyte PCVX Stock Holding History

Trust Company’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$569 Hold
10
– – ﹤0.01% 718
2026
Q2 		$581 Hold
10
– – ﹤0.01% 712
2026
Q1 		$581 Hold
10
– – ﹤0.01% 672
2025
Q4 		$461 Buy
+10
New +$447 ﹤0.01% 719

Other funds holding PCVX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Arizona State Retirement System
Arizona State Retirement System Phoenix, Arizona $20.3B AUM 36.55% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Trust Company's PCVX Position: Q3 2026 in Review

Trust Company held its Vaxcyte (PCVX) position steady in Q3 2026 at 10 shares worth $569. The position accounts for ﹤0.01% of the portfolio, ranked #718.

Trust Company first reported a position in PCVX in Q4 2025 and has held it in 4 quarters since. The position peaked at $581 in Q2 2026. 98 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Trust Company held 10 shares of Vaxcyte worth $569 as of Q3 2026.
  • Trust Company left its Vaxcyte share count unchanged in Q3 2026.
  • Vaxcyte made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #718 holding.
  • Trust Company first reported a position in Vaxcyte in Q4 2025 and has held it in 4 quarters since.
  • Trust Company's Vaxcyte position peaked at $581 in Q2 2026.
  • 98 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.